Skip to main content

Elevance Health Inc Value Stock - Dividend - Research Selection

Anthem

ISIN: US0367521038 , WKN: A12FMV

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Arista Networks and Elevance Health have been highlighted as Zacks Bull and Bear of the Day

2025-09-17
Arista Networks shines with soaring sales and earnings beats, while Elevance Health cuts guidance and struggles in 2025.

Bear of the Day: Elevance Health (ELV)

2025-09-17
Lowered guidance has been a driving force behind the poor share performance, with EPS revisions remaining bearish.

Top 20 Companies Recognized in Labrador Transparency’s 2025 U.S. Transparency Awards

2025-09-16
ATLANTA, September 16, 2025--Lowe’s Companies, Dow, American Express, ConocoPhillips, and AIG secured top honors in the 2025 U.S. Transparency Awards announced today by Labrador Transparency, a leading global communications firm specializing in transparent corporate disclosure documents. The rankings are determined through a rigorous evaluation of corporate disclosure documents and celebrate companies dedicated to building investor and stakeholder trust through clear, concise, and effective comm

Elevance Health (ELV): Exploring Valuation Opportunities as Investor Sentiment Lags Recent Growth

2025-09-16
If Elevance Health (ELV) is on your watchlist, you might be wondering why its shares have slipped this year and whether now offers a window to reconsider your stance. The latest movement is not tied to a particular news event, but it has been enough to catch investors’ attention and stir questions about what the market is signaling for this leading health insurer. In times like these, a valuation reset or an overreaction can create opportunity or signal deeper shifts in sentiment. Looking at...

Elevance Health Inc. stock underperforms Monday when compared to competitors

2025-09-15
Elevance Health Inc. stock underperforms Monday when compared to competitors

New Strong Sell Stocks for September 15th

2025-09-15
CE, ELV and ARR have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2025.

Elevance Health, Inc. (ELV) Reaffirms Full-Year 2025 Earnings Guidance

2025-09-12
Elevance Health, Inc. (NYSE:ELV) is one of the 11 Best Roth IRA Stocks to Invest in Now. Elevance Health, Inc. (NYSE:ELV) announced on September 4, 2025, that it expects to reaffirm its full-year 2025 earnings guidance during upcoming investor meetings. The company expects earnings of roughly $24.10 per diluted share, including roughly $5.90 per share […]

Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?

2025-09-12
ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.

Elevance Health Reduces Medicare Footprint, Exits Standalone Part D Plans for Profitability

2025-09-11
Elevance Health Inc. (NYSE:ELV) is one of the best inexpensive stocks to buy according to hedge funds. On September 4, Elevance’s CFO, Mark Kaye, announced at the Wells Fargo Healthcare Conference in Boston that the company is reducing its Medicare footprint. The decision is being made to improve the business’s profitability, especially in its Medicare […]

Cigna Group Expands Coverage for Home Phototherapy, Benefits Millions with Chronic Skin Conditions

2025-09-11
The Cigna Group (NYSE:CI) is one of the best inexpensive stocks to buy according to hedge funds. On August 29, Phothera announced that Cigna has updated its coverage policy for home phototherapy, effective July 15. The change eliminates prior restrictions on the treatment, expanding access for Cigna’s 19.2 million members nationwide who have chronic skin […]